Yamazaki, K., Kikuchi, M., Nozawa, T., Kanetaka, T., Hara, R., Imagawa, T., . . . Yokota, S. (2013). PReS-FINAL-2189: Tocillizumab for patients with takayasu arteritis in childhood refractory to conventional therapy. BioMed Central.
Chicago-tyylinen lähdeviittausYamazaki, K., et al. PReS-FINAL-2189: Tocillizumab for Patients With Takayasu Arteritis in Childhood Refractory to Conventional Therapy. BioMed Central, 2013.
MLA-viiteYamazaki, K., et al. PReS-FINAL-2189: Tocillizumab for Patients With Takayasu Arteritis in Childhood Refractory to Conventional Therapy. BioMed Central, 2013.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.